122 related articles for article (PubMed ID: 30775274)
1. Loss to follow-up among patients receiving anti-tuberculosis treatment, Haiti, 2011-2015.
Schnaubelt ER; Charles M; Richard M; Fitter DL; Morose W; Cegielski JP
Public Health Action; 2018 Dec; 8(4):154-161. PubMed ID: 30775274
[No Abstract] [Full Text] [Related]
2. Isoniazid mono-resistant tuberculosis: Time to take it seriously.
Garg K; Saini V; Dhillon R; Agarwal P
Indian J Tuberc; 2019 Apr; 66(2):247-252. PubMed ID: 31151492
[TBL] [Abstract][Full Text] [Related]
3. Incidence and predictors of LTFU among adults with TB/HIV co-infection in two governmental hospitals, Mekelle, Ethiopia, 2009-2016: survival model approach.
Gezae KE; Abebe HT; Gebretsadik LG
BMC Infect Dis; 2019 Feb; 19(1):107. PubMed ID: 30717705
[TBL] [Abstract][Full Text] [Related]
4. Microbiologically Confirmed Tuberculosis: Factors Associated with Pre-Treatment Loss to Follow-Up, and Time to Treatment Initiation.
Mwansa-Kambafwile J; Maitshotlo B; Black A
PLoS One; 2017; 12(1):e0168659. PubMed ID: 28068347
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with
Jiang Y; Chen J; Ying M; Liu L; Li M; Lu S; Li Z; Zhang P; Xie Q; Liu X; Lu H
Front Med (Lausanne); 2023; 10():1136094. PubMed ID: 37181365
[TBL] [Abstract][Full Text] [Related]
6. Loss to follow-up among patients diagnosed with spinal tuberculosis at a tertiary hospital in Western Cape Province, South Africa: A retrospective cohort study.
Mann TN; Davis JH; Dyers R
S Afr Med J; 2020 Mar; 110(4):284-290. PubMed ID: 32657739
[TBL] [Abstract][Full Text] [Related]
7. Incidence and predictors of lost to follow-up among drug-resistant tuberculosis patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia: a retrospective follow-up study.
Kassa GM; Teferra AS; Wolde HF; Muluneh AG; Merid MW
BMC Infect Dis; 2019 Sep; 19(1):817. PubMed ID: 31533661
[TBL] [Abstract][Full Text] [Related]
8. "Better to Die Than Take These Medicines": A Community-Based Qualitative Study on the Determinants of Treatment Loss-to-Follow-Up in Tuberculosis Patients in District Faridabad, Haryana, India.
Khaitan A; Rai SK; Krishnan A; Gupta SK; Kant S; Khilnani GC
Cureus; 2022 May; 14(5):e25030. PubMed ID: 35591891
[TBL] [Abstract][Full Text] [Related]
9. High variability in tuberculosis treatment outcomes across 15 health facilities in a semi-urban area in central Ethiopia.
Zenatti G; Raviglione M; Tesfaye F; Bobosha K; Björkman P; Walles J
J Clin Tuberc Other Mycobact Dis; 2023 Feb; 30():100344. PubMed ID: 36578805
[TBL] [Abstract][Full Text] [Related]
10. Loss to follow-up among adolescents with tuberculosis in Gaborone, Botswana.
Enane LA; Lowenthal ED; Arscott-Mills T; Matlhare M; Smallcomb LS; Kgwaadira B; Coffin SE; Steenhoff AP
Int J Tuberc Lung Dis; 2016 Oct; 20(10):1320-1325. PubMed ID: 27725042
[TBL] [Abstract][Full Text] [Related]
11. Risk factors associated with loss to follow-up from tuberculosis treatment in Tajikistan: a case-control study.
Wohlleben J; Makhmudova M; Saidova F; Azamova S; Mergenthaler C; Verver S
BMC Infect Dis; 2017 Aug; 17(1):543. PubMed ID: 28778187
[TBL] [Abstract][Full Text] [Related]
12. [Loss to follow-up in patients treated for multidrug-resistant tuberculosis in EcuadorA Perda de seguimento de pacientes tratados para tuberculose multirresistente a medicamentos no Equador].
Tatés-Ortega N; Álvarez J; López L; Mendoza-Ticona A; Alarcón-Arrascue E
Rev Panam Salud Publica; 2019; 43():e91. PubMed ID: 31892925
[TBL] [Abstract][Full Text] [Related]
13. Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi.
Tweya H; Oboho IK; Gugsa ST; Phiri S; Rambiki E; Banda R; Mwafilaso J; Munthali C; Gupta S; Bateganya M; Maida A
PLoS One; 2018; 13(1):e0188488. PubMed ID: 29373574
[TBL] [Abstract][Full Text] [Related]
14. Tuberculosis cohort analysis in Zimbabwe: The need to strengthen patient follow-up throughout the tuberculosis care cascade.
Mando TC; Sandy C; Chadambuka A; Gombe NT; Juru TP; Shambira G; Umeokonkwo CD; Tshimanga M
PLoS One; 2023; 18(11):e0293867. PubMed ID: 37939099
[TBL] [Abstract][Full Text] [Related]
15. Predictors of loss to follow-up of tuberculosis cases under the DOTS programme in Namibia.
Kibuule D; Aiases P; Ruswa N; Rennie TW; Verbeeck RK; Godman B; Mubita M
ERJ Open Res; 2020 Jan; 6(1):. PubMed ID: 32201689
[TBL] [Abstract][Full Text] [Related]
16. Treatment outcomes among children, adolescents, and adults on treatment for tuberculosis in two metropolitan municipalities in Gauteng Province, South Africa.
Berry KM; Rodriguez CA; Berhanu RH; Ismail N; Mvusi L; Long L; Evans D
BMC Public Health; 2019 Jul; 19(1):973. PubMed ID: 31331311
[TBL] [Abstract][Full Text] [Related]
17. TB treatment non-adherence in São Tomé and Príncipe.
Bandeira S; da Trindade S; Raguenaud ME; Sousa B
Public Health Action; 2022 Dec; 12(4):195-200. PubMed ID: 36561905
[TBL] [Abstract][Full Text] [Related]
18. A combination of quantitative and qualitative methods in investigating risk factors for lost to follow-up for tuberculosis treatment in Japan - Are physicians and nurses at a particular risk?
Kawatsu L; Uchimura K; Ohkado A; Kato S
PLoS One; 2018; 13(6):e0198075. PubMed ID: 29906287
[TBL] [Abstract][Full Text] [Related]
19. Machine learning algorithms using national registry data to predict loss to follow- up during tuberculosis treatment.
Rodrigues MMS; Barreto-Duarte B; Vinhaes CL; Araújo-Pereira M; Fukutani ER; Bergamaschi KB; Kristki A; Cordeiro-Santos M; Rolla VC; Sterling TR; Queiroz ATL; Andrade BB
Res Sq; 2023 Dec; ():. PubMed ID: 38168296
[TBL] [Abstract][Full Text] [Related]
20. Treatment outcomes of TB-infected individuals attending public sector primary care clinics in rural Liberia from 2015 to 2017: a retrospective cohort study.
Wickett E; Peralta-Santos A; Beste J; Micikas M; Toe F; Rogers J; Jabateh L; Wagenaar BH
Trop Med Int Health; 2018 May; 23(5):549-557. PubMed ID: 29524302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
